{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Nutriband, Inc.
Is Nutriband, Inc. overvalued or undervalued?
As of October 5, 2023, Nutriband, Inc. is considered undervalued with a P/E ratio of 12.5 and a P/B ratio of 1.8, indicating an attractive investment compared to peers, and its recent stock performance suggests the market may not fully recognize its growth potential.
Is Nutriband, Inc. technically bullish or bearish?
As of October 5, 2023, there is insufficient technical data for Nutriband, Inc. to determine if it is bullish or bearish.
What does Nutriband, Inc. do?
Nutriband, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $1 million and a net loss of $1 million as of April 2025. Key financial metrics include a market cap of $86.44 million, a P/E ratio of NA, and a dividend yield of 0.00%.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
